New Triple-Threat treatment aims to shrink rectal tumors and save patients from colostomy bags
NCT ID NCT07397442
Summary
This study is testing whether combining short radiation therapy, two immunotherapy drugs, and chemotherapy can shrink rectal tumors enough to avoid permanent colostomy bags. All 19 participants will receive the same experimental treatment, which aims to completely eliminate tumors in over half of patients. Researchers will monitor patients for five years to check if the cancer returns and assess their quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER STAGE II are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 100050, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.